Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Synovus Financial Turns To Profit In Q1 Vs Loss Last Year - Quick Facts

RELATED NEWS
Trade SNV now with 

Synovus Financial Corp. (SNV: Quote) reported net profit available to common shareholders for the first quarter of 2012 of $21.40 million or $0.024 per share versus loss of $93.70 million or $0.119 loss per diluted share reported for the corresponding first quarter of 2011.

On average, 21 analysts polled by Thomson Reuters expected the company to report $0.01 per share for the quarter. Analysts' estimates typically exclude special items.

Net interest income for the first quarter of 2012 declined to $220.96 million from $237.43 million in the corresponding quarter last year.

Total non-interest income, however, increased to $84.14 million from $64.16 million a year ago. Analysts estimated revenues of $287.10 million.

Click here to receive FREE breaking news email alerts for Synovus Financial and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After initially showing a lack of direction, stocks have moved mostly higher over the course of the trading day on Friday. With the gains on the day, the markets are extending the upward trend seen over the past several sessions. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections. While the Commerce Department released a report on Friday showing a modest increase in new home sales in the U.S. in the month of September, the uptick came from a significantly downwardly revised level in August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.